Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses
暂无分享,去创建一个
Xin Sun | Gordon H Guyatt | Matthias Briel | Stephen D Walter | G. Guyatt | S. Walter | M. Briel | Xin Sun
[1] G. Van den Berghe,et al. Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.
[2] Gordon H. Guyatt,et al. The safety of long-acting beta-agonists among patients with asthma using inhaled corticosteroids: systematic review and metaanalysis. , 2008, American journal of respiratory and critical care medicine.
[3] A R Feinstein,et al. The problem of cogent subgroups: a clinicostatistical tragedy. , 1998, Journal of Clinical Epidemiology.
[4] S. Assmann,et al. Subgroup analysis and other (mis)uses of baseline data in clinical trials , 2000, The Lancet.
[5] Nancy R Cook,et al. Use of aspirin as primary prevention of cardiovascular events. , 2006, JAMA.
[6] D. Moher,et al. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials , 2010, BMC medicine.
[7] D G Altman,et al. Within trial variation--a false trail? , 1998, Journal of clinical epidemiology.
[8] R. McKelvie,et al. Necessary cautions when considering digoxin in heart failure , 2007, Canadian Medical Association Journal.
[9] M H Cullen,et al. The benefits of chemotherapy in patient subgroups with unresectable non-small-cell lung cancer. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.
[10] Gordon H. Guyatt,et al. Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice; Users' Guides to the Medical Literature: Essentials of Evidence-Based Clinical Practice , 2003, BMJ : British Medical Journal.
[11] G H Guyatt,et al. A Consumer's Guide to Subgroup Analyses , 1992, Annals of Internal Medicine.
[12] Nick Freemantle,et al. Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic? , 2001, BMJ : British Medical Journal.
[13] J. Wittes,et al. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. , 1991, JAMA.
[14] Augusto Sarmiento,et al. Randomized trial of reamed and unreamed intramedullary nailing of tibial shaft fractures. , 2008, The Journal of bone and joint surgery. American volume.
[15] An-Wen Chan,et al. Bias, Spin, and Misreporting: Time for Full Access to Trial Protocols and Results , 2008, PLoS medicine.
[16] Marc F. Swiontkowski. Randomized Trial of Reamed and Unreamed Intramedullary Nailing of Tibial Shaft Fractures , 2009 .
[17] Gordon Guyatt,et al. Tips for learners of evidence-based medicine: 4. Assessing heterogeneity of primary studies in systematic reviews and whether to combine their results , 2005, Canadian Medical Association Journal.
[18] Gordon Guyatt,et al. Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis. , 2002, Endocrine reviews.
[19] R W Makuch,et al. On reaching the tunnel at the end of the light. , 1997, Journal of clinical epidemiology.
[20] R W Makuch,et al. Clinical versus statistical considerations in the design and analysis of clinical research. , 1998, Journal of clinical epidemiology.
[21] James E Dalen. Use of aspirin as primary prevention of cardiovascular events. , 2006, JAMA.
[22] Philipp Dahm,et al. Evidence‐based urology in practice: when to believe a subgroup analysis? , 2010, BJU international.
[23] Gordon H. Guyatt,et al. Naturopathic Care for Chronic Low Back Pain: A Randomized Trial , 2007, PloS one.
[24] Gianni Tognoni,et al. Aspirin for the Primary Prevention of Cardiovascular Events in Women and Men: A Sex-Specific Meta-Analysis of Randomized Controlled Trials , 2006, JAMA.
[25] S Senn,et al. On wisdom after the event. , 1997, Journal of clinical epidemiology.
[26] M Alan Brookhart,et al. Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. , 2006, Archives of internal medicine.
[27] Gordon Guyatt,et al. Meta-analyses of therapies for postmenopausal osteoporosis. I. Systematic reviews of randomized trials in osteoporosis: introduction and methodology. , 2002, Endocrine reviews.
[28] Jan Brozek,et al. The safety of long-acting beta-agonists among patients with asthma using inhaled corticosteroids: systematic review and metaanalysis. , 2008, American journal of respiratory and critical care medicine.
[29] M. Egger,et al. Incommunicable knowledge? Interpreting and applying the results of clinical trials and meta-analyses. , 1998, Journal of clinical epidemiology.
[30] Sangeeta Mehta,et al. Vasopressin versus norepinephrine infusion in patients with septic shock. , 2008, The New England journal of medicine.
[31] Emil H Schemitsch,et al. Randomized trial of reamed and unreamed intramedullary nailing of tibial shaft fractures. , 2008, The Journal of bone and joint surgery. American volume.
[32] Marjorie S Rosenthal,et al. Interpreting subgroup analyses: is a school-based asthma treatment program's effect modified by secondhand smoke exposure? , 2004, Archives of pediatrics & adolescent medicine.
[33] Michael A Babyak,et al. What You See May Not Be What You Get: A Brief, Nontechnical Introduction to Overfitting in Regression-Type Models , 2004, Psychosomatic medicine.
[34] Elie A Akl,et al. Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: a systematic review and meta-analysis. , 2008, Archives of internal medicine.
[35] Holger J Schünemann,et al. Misuse of Baseline Comparison Tests and Subgroup Analyses in Surgical Trials , 2006, Clinical orthopaedics and related research.
[36] Kristian Thorlund,et al. Cooling for Neonatal Hypoxic Ischemic Encephalopathy: Do We Have the Answer? , 2007, Pediatrics.
[37] Kevin Carroll,et al. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer) , 2005, The Lancet.
[38] Stephen W Lagakos,et al. Statistics in medicine--reporting of subgroup analyses in clinical trials. , 2007, The New England journal of medicine.
[39] R W Makuch,et al. Can treatment that is helpful on average be harmful to some patients? A study of the conflicting information needs of clinical inquiry and drug regulation. , 1996, Journal of clinical epidemiology.